By Editor • September 2, 2026 • 1 min read
Trump's new drug pricing deals with biotech firms may not effectively reduce costs, primarily impacting Medicaid but exempting Medicare.
Read moreBy Editor • September 1, 2026 • 1 min read
The Trump administration's announcement of drug pricing deals raises significant unanswered questions about their implications.
Read moreBy Editor • August 28, 2026 • 1 min read
Medicare's new billing code intended to enhance relationship-based care for patients may not be achieving its goals.
Read moreBy Editor • August 27, 2026 • 1 min read
The CMS is set to unveil ACCESS, a pilot program focused on improving chronic care management for Medicare recipients.
Read moreBy Editor • August 25, 2026 • 2 min read
Medicare's new GLP-1 discount program is leaving many patients like Jeff La Marca, who struggle with severe health conditions, without access to affordable treatment.
Read moreBy Editor • August 19, 2026 • 2 min read
Cataract surgery costs are rising as more patients choose laser options, despite studies showing little difference in outcomes compared to traditional methods.
Read more
